» Articles » PMID: 10808176

Fetal and Neonatal IL-13 Production During Pregnancy and at Birth and Subsequent Development of Atopic Symptoms

Overview
Date 2000 May 16
PMID 10808176
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cytokine production at the materno-fetal interface may influence the development of atopy-predisposing immune responses. Because IL-13 possesses IL-4-like activity and may regulate the immune responses observed in atopy, it may contribute to the expression of the atopic phenotype initiated during intrauterine life.

Objective: We sought to examine IL-13 expression by fetal and neonatal cells and the placenta.

Methods: The production of IL-13 by neonatal and fetal T cells was examined by culturing the cells in the presence or absence of PHA. Production of IL-13 at term was considered in the context of the later development of atopic disease in the child. IL-13 expression in the placenta was assessed by using immunohistochemistry.

Results: IL-13 immunoreactivity within the placenta was restricted to 16 to 27 weeks' gestation (6/6 positive vs 0/10 at >27 weeks' gestation). In contrast, spontaneous release of IL-13 by fetal mononuclear cells was first observed from 27 weeks' gestation but was undetectable after 37 weeks' gestation. PHA-stimulated mononuclear cells showed increased IL-13 levels in 80% of samples. Term babies (>37 weeks' gestation) with a parental history of atopy with atopic symptoms by 3 years of age produced significantly lower concentrations of PHA-induced IL-13 when compared with babies with no parental history of atopy (P =.034).

Conclusion: Thus babies at risk of atopic disease in infancy display defective IL-13 production at birth. This may represent an inherent immaturity in the development of T cell-cytokine responses in babies at genetic risk for atopy or could be a consequence of downregulation of responses by other factors. Normal pregnancy, irrespective of atopic status, is associated with the production of appreciable quantities of IL-13 initially by the placenta and subsequently by the fetus. The regulation of this production and its consequences for the mother and fetus remains to be elaborated.

Citing Articles

Multi-locus high-risk alleles association from interleukin's genes with female infertility and certain comorbidities.

Khashei Varnamkhasti K, Khashei Varnamkhasti S, Bahraini N, Davoodi M, Sadeghian M, Khavanin M BMC Res Notes. 2024; 17(1):344.

PMID: 39580416 PMC: 11585211. DOI: 10.1186/s13104-024-06988-1.


Amniotic fluid modifies esophageal epithelium differentiation and inflammatory responses.

Rochman M, Klinger A, Caldwell J, Sadovsky Y, Rothenberg M Am J Physiol Gastrointest Liver Physiol. 2024; 327(5):G629-G639.

PMID: 39189791 PMC: 11559652. DOI: 10.1152/ajpgi.00197.2024.


Cytokine production by newborns: influence of sex and season of birth.

Garcia-Serna A, Morales E, Cantero-Cano E, Norte-Munoz M, Gil-Buendia M, Velazquez-Marin J Pediatr Res. 2022; 93(3):526-534.

PMID: 35945266 DOI: 10.1038/s41390-022-02153-1.


The Foetal Origins of Allergy and Potential Nutritional Interventions to Prevent Disease.

Warner J, Warner J Nutrients. 2022; 14(8).

PMID: 35458152 PMC: 9026316. DOI: 10.3390/nu14081590.


Tendon Immune Regeneration: Insights on the Synergetic Role of Stem and Immune Cells during Tendon Regeneration.

Russo V, El Khatib M, Prencipe G, Citeroni M, Faydaver M, Mauro A Cells. 2022; 11(3).

PMID: 35159244 PMC: 8834336. DOI: 10.3390/cells11030434.